$IMUC
EOM Pharmaceutical Holdings, Inc.

2014 Q2 Form 10-Q Financial Statement

#000156459014002006 Filed on May 09, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $970.0K $1.050M $930.0K
YoY Change 0.0% 12.9% -11.43%
% of Gross Profit
Research & Development $1.460M $1.700M $1.415M
YoY Change 20.66% 20.1% -29.19%
% of Gross Profit
Depreciation & Amortization $11.28K $12.63K $10.84K
YoY Change 4.07% 16.53% -5.26%
% of Gross Profit
Operating Expenses $2.427M $2.749M $1.415M
YoY Change 11.32% 94.26% -29.19%
Operating Profit -$2.427M -$2.749M -$2.349M
YoY Change 11.22% 17.06% -22.98%
Interest Expense $230.0K -$410.0K -$2.630M
YoY Change -88.67% -84.41% -45.66%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.199M -$3.162M -$4.974M
YoY Change 1362.88% -36.43% -36.96%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.199M -$3.162M -$4.974M
YoY Change 1362.88% -36.43% -36.96%
Net Earnings / Revenue
Basic Earnings Per Share -$0.04 -$0.05 -$0.10
Diluted Earnings Per Share -$0.04 -$0.05 -$0.10
COMMON SHARES
Basic Shares Outstanding 57.92M 57.57M
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.66M $25.03M $24.10M
YoY Change 0.83% 3.86% 77.73%
Cash & Equivalents $25.66M $25.03M $24.10M
Short-Term Investments
Other Short-Term Assets $970.0K $730.0K $818.0K
YoY Change 142.5% -10.76% 10.55%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $26.63M $25.76M $24.92M
YoY Change 3.02% 3.36% 74.28%
LONG-TERM ASSETS
Property, Plant & Equipment $50.00K $60.00K $61.63K
YoY Change -44.44% -2.64% -43.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $460.0K $460.0K $90.00K
YoY Change 90.42% 411.11% 800.0%
Total Long-Term Assets $510.0K $520.0K $148.4K
YoY Change 54.55% 250.49% 23.64%
TOTAL ASSETS
Total Short-Term Assets $26.63M $25.76M $24.92M
Total Long-Term Assets $510.0K $520.0K $148.4K
Total Assets $27.14M $26.28M $25.07M
YoY Change 3.67% 4.82% 73.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $620.0K $570.0K $705.9K
YoY Change 87.88% -19.25% 0.84%
Accrued Expenses $500.0K $740.0K $362.3K
YoY Change 2.04% 104.26% -51.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.120M $1.310M $1.158M
YoY Change 36.59% 13.14% -19.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.260M $1.480M $5.480M
YoY Change -45.45% -72.99% -14.64%
Total Long-Term Liabilities $1.260M $1.480M $5.480M
YoY Change -45.45% -72.99% -14.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.120M $1.310M $1.158M
Total Long-Term Liabilities $1.260M $1.480M $5.480M
Total Liabilities $2.380M $2.790M $6.640M
YoY Change -23.96% -57.98% -15.63%
SHAREHOLDERS EQUITY
Retained Earnings -$48.14M
YoY Change
Common Stock $5.167K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.76M $23.50M $18.43M
YoY Change
Total Liabilities & Shareholders Equity $27.14M $26.28M $25.07M
YoY Change 3.67% 4.82% 73.86%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$2.199M -$3.162M -$4.974M
YoY Change 1362.88% -36.43% -36.96%
Depreciation, Depletion And Amortization $11.28K $12.63K $10.84K
YoY Change 4.07% 16.53% -5.26%
Cash From Operating Activities -$2.710M -$2.614M -$2.207M
YoY Change 41.88% 18.42% -38.32%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $3.600K $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$3.200K $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $431.8K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.330M 0.000 94.86K
YoY Change 0.91% -100.0% -99.1%
NET CHANGE
Cash From Operating Activities -2.710M -2.614M -2.207M
Cash From Investing Activities 0.000 -3.200K 0.000
Cash From Financing Activities 3.330M 0.000 94.86K
Net Change In Cash 620.0K -2.617M -2.112M
YoY Change -54.41% 23.88% -130.6%
FREE CASH FLOW
Cash From Operating Activities -$2.710M -$2.614M -$2.207M
Capital Expenditures $0.00 $3.600K $0.00
Free Cash Flow -$2.710M -$2.617M -$2.207M
YoY Change 44.15% 18.58% -38.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51969393
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1402273
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28940677
CY2013Q4 us-gaap Assets
Assets
28940677
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1064810
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
5754
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
357265
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
861026
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
464585
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
78437233
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
26473594
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
149000000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57542231
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57542231
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
183982
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
184102
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
865402
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
2749264
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2749264
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3354
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
397294
CY2014Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-416067
CY2013Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2631683
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1439564
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3161977
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4973791
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-53038870
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-3161977
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-4973791
us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
2092500
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3161977
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4973791
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-55131370
CY2014Q1 imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-0.05
CY2013Q1 imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-0.10
imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-2.59
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
51547632
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21312055
CY2004Q1 us-gaap Stockholders Equity
StockholdersEquity
97
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
150
us-gaap Net Income Loss
NetIncomeLoss
-11741
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
-11494
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-246004
CY2006 imuc Common Stock Issued For Cash During Private Placements Net Of Redemptions
CommonStockIssuedForCashDuringPrivatePlacementsNetOfRedemptions
549400
CY2006 imuc Share Cancelled In Connection With Sale Of Affiliate
ShareCancelledInConnectionWithSaleOfAffiliate
65000
CY2006 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3522
CY2006 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4103645
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
763299
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57922304
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000822411
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q4 us-gaap Assets Current
AssetsCurrent
28409650
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66442
us-gaap Net Income Loss
NetIncomeLoss
-53038870
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57552664
CY2007 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4892486
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27646351
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1699760
CY2006 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-5152713
us-gaap Depreciation
Depreciation
138321
CY2007 imuc Reclassification Of Warrant Derivative Liability
ReclassificationOfWarrantDerivativeLiability
2233600
CY2007 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1296714
CY2007 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-3614753
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
4997709
CY2008 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
513357
CY2008 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-3059730
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
2940336
CY2009 imuc Exercise Of Warrants
ExerciseOfWarrants
462748
CY2009 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11814
CY2009 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
308302
CY2009 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-2626205
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
1096995
CY2010 imuc Common Stock And Warrants Issued For Cash Net Of Offering Costs
CommonStockAndWarrantsIssuedForCashNetOfOfferingCosts
3248738
CY2010 imuc Preferred Stock And Warrants Issued For Cash Net Of Offering Costs
PreferredStockAndWarrantsIssuedForCashNetOfOfferingCosts
CY2010 imuc Redemption Of Preferred Stock For Repayment Of Promissory Note
RedemptionOfPreferredStockForRepaymentOfPromissoryNote
3307500
CY2010 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26500
CY2010 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
745697
CY2010 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
CY2010 imuc Interest On Promissory Note
InterestOnPromissoryNote
1614
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-6150142
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
2335830
CY2011 imuc Common Stock And Warrants Issued For Cash Net Of Offering Costs
CommonStockAndWarrantsIssuedForCashNetOfOfferingCosts
4983339
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
388379
CY2011 imuc Interest On Promissory Note
InterestOnPromissoryNote
352
CY2011 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
54634
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-5719903
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
3232060
CY2012 imuc Exercise Of Warrants
ExerciseOfWarrants
3201920
CY2012 imuc Reclassification Of Warrant Derivative Liability
ReclassificationOfWarrantDerivativeLiability
1981743
CY2012 imuc Restricted Stock Value Shares Issued Vested
RestrictedStockValueSharesIssuedVested
CY2012 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20500
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-14495139
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
23068014
CY2013 imuc Exercise Of Warrants
ExerciseOfWarrants
6176336
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
324517
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
724212
CY2013 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-8800563
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
184102
CY2013 imuc Initial Capitalization Per Share
InitialCapitalizationPerShare
0.00002
CY2013 imuc Common Stock Issued For Cash Per Share
CommonStockIssuedForCashPerShare
0.00078
CY2005 imuc Common Stock Issued For Research And Development Per Share
CommonStockIssuedForResearchAndDevelopmentPerShare
0.99
CY2006 imuc Common Stock Issued For Services Per Share
CommonStockIssuedForServicesPerShare
0.50
CY2006 imuc Common Stock Issued For Cash In Private Placements Per Share
CommonStockIssuedForCashInPrivatePlacementsPerShare
1.00
CY2006 imuc Common Stock Issued For Research And Development Per Share
CommonStockIssuedForResearchAndDevelopmentPerShare
1.00
CY2007 imuc Common Stock Issued For Cash In Private Placements Per Share
CommonStockIssuedForCashInPrivatePlacementsPerShare
1.50
CY2010 imuc Common Stock And Warrants Issued For Cash Per Share
CommonStockAndWarrantsIssuedForCashPerShare
1.00
CY2010 imuc Preferred Stock And Warrants Issued For Cash Per Share
PreferredStockAndWarrantsIssuedForCashPerShare
10000
CY2011 imuc Common Stock And Warrants Issued For Cash Per Share
CommonStockAndWarrantsIssuedForCashPerShare
1.55
CY2014Q1 us-gaap Depreciation
Depreciation
12634
CY2012 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
496007
CY2013Q1 us-gaap Depreciation
Depreciation
10842
CY2014Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4
CY2013Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3817
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3813
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
184102
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
164128
us-gaap Share Based Compensation
ShareBasedCompensation
9562170
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-228264
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
84131
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
775230
CY2013Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
10732
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
8695343
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
53018
imuc Proceeds From Issuance Of Common Stock And Warrants From Underwritten Public Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromUnderwrittenPublicOffering
51899857
imuc Proceeds From Issuance Of Preferred Stock And Warrants Net Of Offering Costs
ProceedsFromIssuanceOfPreferredStockAndWarrantsNetOfOfferingCosts
3779158
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
98703
imuc Common Stock Issued For Research And Development
CommonStockIssuedForResearchAndDevelopment
1335760
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-30927
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
103533
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1188120
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-290665
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-26953
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
212746
CY2014Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-203464
CY2013Q1 us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
-219647
us-gaap Increase Decrease In Workers Compensation Liabilities
IncreaseDecreaseInWorkersCompensationLiabilities
153801
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
398622
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
306181
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
939869
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2613758
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2207273
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39944949
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3600
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
203664
CY2014Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
400
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
400
us-gaap Payments For Proceeds From Businesses And Interest In Affiliates
PaymentsForProceedsFromBusinessesAndInterestInAffiliates
25000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3200
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
94863
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
65202606
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2616958
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2112410
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25029393
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26216668
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24104258
CY2014Q1 us-gaap Interest Paid
InterestPaid
CY2013Q1 us-gaap Interest Paid
InterestPaid
us-gaap Interest Paid
InterestPaid
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
imuc Exercise Of Warrants In Exchange For Promissory Note
ExerciseOfWarrantsInExchangeForPromissoryNote
3350000
imuc Redemption Of Preferred Stock For Repayment Of Promissory Note
RedemptionOfPreferredStockForRepaymentOfPromissoryNote
3350000
imuc Warrant Liability Converted To Additional Paid In Capital Upon Exercise
WarrantLiabilityConvertedToAdditionalPaidInCapitalUponExercise
3127404
us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
35882
imuc Non Cash Deferred Offering Costs
NonCashDeferredOfferingCosts
182599
CY2013Q1 imuc Common Stock Issued For License Rights
CommonStockIssuedForLicenseRights
75000
imuc Common Stock Issued For License Rights
CommonStockIssuedForLicenseRights
75000
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.86%;font-size:10pt;font-family:Times New Roman;"><font style="font-style:italic;;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.86%;">Use of Estimates</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.86%;"> &#8211; The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions about the future outcome of current transactions which may affect the reporting and disclosure of these transactions. Accordingly, actual results could differ from those estimates used in the preparation of these financial statements.</font></p></div>
CY2014Q1 imuc Working Capital
WorkingCapital
24459999
CY2013Q4 imuc Working Capital
WorkingCapital
27007377
CY2014Q1 imuc Maturity Period Of Highly Liquid Instruments To Be Considered As Cash Equivalents Maximum
MaturityPeriodOfHighlyLiquidInstrumentsToBeConsideredAsCashEquivalentsMaximum
P90D
CY2014Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
23917247
CY2013Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
25913893
CY2014Q1 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
generally three to five years
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0223
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.00074
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.953
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.906
CY2014Q1 imuc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate
0.00
CY2013Q1 imuc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate
0.00
CY2014Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
56617706
CY2014Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20551398
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24172596
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
176886
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
185375
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
119874
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118933
CY2006Q4 imuc Stock Issued During Period Shares Issued For Upfront Licensing Fee
StockIssuedDuringPeriodSharesIssuedForUpfrontLicensingFee
694000
CY2006Q4 imuc Payment For Upfront Licensing Fee
PaymentForUpfrontLicensingFee
62000
CY2008Q4 imuc Funding From Equity For Milestone Minimum
FundingFromEquityForMilestoneMinimum
5000000
CY2009Q4 imuc Payment To Related Party For Clinical Trial
PaymentToRelatedPartyForClinicalTrial
166660
CY2008Q2 imuc Stock Issued During Period Shares Issued For Additional Licensing Fee
StockIssuedDuringPeriodSharesIssuedForAdditionalLicensingFee
100000
CY2011Q3 imuc Amount Of Funding From Equity Minimum After Amendment
AmountOfFundingFromEquityMinimumAfterAmendment
5000000
CY2010Q4 imuc Amount Of Funding From Equity Minimum After Amendment
AmountOfFundingFromEquityMinimumAfterAmendment
2500000
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
210856
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
446142
CY2014Q1 imuc Extended Term Of Agreement
ExtendedTermOfAgreement
2014-03-31
CY2014Q1 imuc Period Within Effective Date Of License Agreement
PeriodWithinEffectiveDateOfLicenseAgreement
P30D
CY2014Q1 imuc Nonrefundable And Noncreditable License And Maintenance Fee
NonrefundableAndNoncreditableLicenseAndMaintenanceFee
P12M
CY2014Q1 us-gaap Rental Properties
RentalProperties
8063
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
24000
CY2013Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
13000
CY2014Q1 imuc Percentage Of Annual Increase Of Monthly Base Rent
PercentageOfAnnualIncreaseOfMonthlyBaseRent
0.03
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
73535
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
100905
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
68432
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
242872
CY2013Q2 imuc Rate Of Commission
RateOfCommission
0.030
CY2013Q2 imuc Listing Of Shares Of Common Stock In Connection With Sales Agreement
ListingOfSharesOfCommonStockInConnectionWithSalesAgreement
10593220
CY2013 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
338000
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
356600
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
431776
CY2014Q1 imuc Percentage Of Fair Market Value Of Common Stock
PercentageOfFairMarketValueOfCommonStock
not be less than 100%
CY2014Q1 imuc Percentage Of Common Stock Voting Rights Held
PercentageOfCommonStockVotingRightsHeld
more than 10%
CY2014Q1 imuc Minimum Percentage Of Fair Market Value Of Common Stock
MinimumPercentageOfFairMarketValueOfCommonStock
less than 110%
CY2014Q1 imuc Maximum Exercisable Period Of Options
MaximumExercisablePeriodOfOptions
P10Y
CY2014Q1 imuc Maximum Exercisable Period Of Options If Percentage Of Common Stock Voting Rights Held Is More Than Ten Percent
MaximumExercisablePeriodOfOptionsIfPercentageOfCommonStockVotingRightsHeldIsMoreThanTenPercent
P5Y
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
12000000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
8000000
CY2005Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
6000000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5554114
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10466695
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
330000
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
75000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
170313
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10551382
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8756944
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.37
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.34
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.90
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.71
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.32
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.15
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M18D
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y10M28D
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1629842
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1629842
CY2014Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2400000
CY2014Q1 imuc Employee Service Share Based Compensation Nonvested Awards Compensation Cost Not Yet Recognized Period For Recognition Maximum
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedPeriodForRecognitionMaximum
20
CY2010Q2 imuc Warrants Exercisable Period After Initial Issuance
WarrantsExercisablePeriodAfterInitialIssuance
P5Y
CY2011Q1 imuc Warrants Exercisable Period After Initial Issuance
WarrantsExercisablePeriodAfterInitialIssuance
P5Y
CY2012Q4 imuc Common Stock Of Public Offering
CommonStockOfPublicOffering
2823670
CY2012Q4 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.87
CY2014Q1 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
2823670
CY2012Q1 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
1.41
CY2012Q1 imuc Common Stock Shares Issuable Private Placement Warrants
CommonStockSharesIssuablePrivatePlacementWarrants
4744718
CY2012Q1 imuc Warrants Exercisable Period After Initial Issuance
WarrantsExercisablePeriodAfterInitialIssuance
P5Y
CY2014Q1 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
1.22
CY2013 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
0.93
CY2010Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
834455
CY2012Q1 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.87
CY2012Q4 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
2823670
CY2014Q1 imuc Charge To Financing Expense
ChargeToFinancingExpense
397294
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2852879
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0
CY2014Q1 imuc Warrants Exercised
WarrantsExercised
0
CY2014Q1 imuc Warrant Liability Gain Loss Included In Earnings
WarrantLiabilityGainLossIncludedInEarnings
416067
CY2013Q1 imuc Warrant Liability Gain Loss Included In Earnings
WarrantLiabilityGainLossIncludedInEarnings
2631683
CY2014Q1 imuc Warrants Liability Transfers Net
WarrantsLiabilityTransfersNet
0
CY2013Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
5484562
CY2014Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2013Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
CY2014Q1 imuc Change In Fair Value Of Warrant Liability For Income Taxes
ChangeInFairValueOfWarrantLiabilityForIncomeTaxes
0.05
CY2013Q1 imuc Change In Fair Value Of Warrant Liability For Income Taxes
ChangeInFairValueOfWarrantLiabilityForIncomeTaxes
0.21
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.35
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.19
CY2014Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.00
CY2013Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.00
CY2014Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16900628
CY2013Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15759274
CY2014Q1 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
2094628
CY2013Q1 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
2020987
CY2014Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18995256
CY2013Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17780261
CY2014Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2013Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2014Q1 imuc Net Operating Losses Expire Date
NetOperatingLossesExpireDate
expire in 2022 and 2016

Files In Submission

Name View Source Status
0001564590-14-002006-index-headers.html Edgar Link pending
0001564590-14-002006-index.html Edgar Link pending
0001564590-14-002006.txt Edgar Link pending
0001564590-14-002006-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
imuc-10q_20140331.htm Edgar Link pending
imuc-20140331.xml Edgar Link completed
imuc-20140331.xsd Edgar Link pending
imuc-20140331_cal.xml Edgar Link unprocessable
imuc-20140331_def.xml Edgar Link unprocessable
imuc-20140331_lab.xml Edgar Link unprocessable
imuc-20140331_pre.xml Edgar Link unprocessable
imuc-ex31_20140331149.htm Edgar Link pending
imuc-ex31_20140331150.htm Edgar Link pending
imuc-ex32_20140331151.htm Edgar Link pending
imuc-ex32_20140331152.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending